1）日本胆道外科研究会（編）：胆道癌取扱い規約 第5版．金原出版，2003
2）日本肝胆膵外科学会（編）：胆道癌取扱い規約 第6版．金原出版，2013
3）日本肝癌研究会（編）：原発性肝癌取扱い規約 第6版．金原出版，2015
4）Valle J, Wasan H, Palmer DH, et al；ABC-02 Trial Investigators：Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362：1273-1281, 2010
5）日本肝胆膵外科学会 胆道癌進路湯ガイドライン作成委員会（編）：胆道癌診療ガイドライン 改訂第2版．医学図書出版，2014
6）Kanai M, Hatano E, Kobayashi S, et al：A multi-institution phase Ⅱ study of gemcitabine/cisplatin/S-1（GCS）combination chemotherapy for patients with advanced biliary tract cancer（KHBO 1002）. Cancer Chemother Pharmacol 75：293-300, 2015
7）Miyakawa S, Ishihara S, Horiguchi A, et al：Biliary tract cancer treatment：5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg 16：1-7, 2009
8）Primrose JN, Fox RP, Palmer D, et al：Adjuvant capecitabine for biliary tract cancer：the BILCAP randomized study. ASCO Annual Meeting, 2017.
9）Kobayashi S, Miyamoto A, Shimizu J, et al：Comparison of 4-weekly vs 3-weekly gemcitabine as adjuvant chemotherapy following curative resection for biliary tract cancer：A prospective randomized controlled trial. J Cancer Ther 2：703-709, 2011
10）Kobayashi S, Nagano H, Sakai D, et al：Phase Ⅰ study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy：KHBO1003 study. Cancer Chemother Pharmacol 74：699-709, 2014
11）Toyoda M, Ajiki T, Fujiwara Y, et al：Phase Ⅰ study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy（KHBO1004）Cancer Chemother Pharmacol 73：1295-1301, 2014
12）Kobayashi S, Tomokuni A, Gotoh K, et al：A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer. Eur J Surg Oncol 43：763-771, 2017
13）Unno M, Okumoto T, Katayose Y, et al：Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 14：434-440, 2007
14）Kobayashi S, Nagano H, Marubashi S, et al：Multidetector computed tomography for preoperative prediction of postsurgical prognosis of patients with extrahepatic biliary cancer. J Surg Oncol 101：376-383, 2010
15）Kobayashi S, Nagano H, Hoshino H, et al：Diagnostic value of FDG-PET for lymp node metastasis and outcome of surgery for biliary cancer. J Surg Oncol 103：223-229, 2011
16）Hashimoto K, Tono T, Nishida K, et al：A case of curatively resected advanced intrahepatic cholangiocellular carcinoma through effective response to neoadjuvant chemotherapy. Gan To Kagaku Ryoho 41：2083-2085, 2014
17）Gotoh K, Marubashi S, Kobayashi S, et al：Successful treatment of advanced gallbladder cancer involving the extrahepatic bile duct with neoadjuvant chemoradiation therapy-a case report. Gan To Kagaku Ryoho 41：1515-1517, 2014
18）Okumura T, Nakamura J, Kai K, et al：Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1：report of a case. World J Surg Oncol 12：326, 2014
19）Yamada I, Shinozaki K, Ajiki T, et al：A case involving long-term survival following bile duct cancer with para-aortic lymph node metastasis that was treated by multidisciplinary therapy. Gan To Kagaku Ryoho 40：1741-1743, 2013
20）Kawashima H, Takeda Y, Nakahira S, et al：A case of advanced cholangiolocellular carcinoma successfully treated by neoadjuvant chemotherapy with gemcitabine followed by radical resection. Gan To Kagaku Ryoho 39：2113-2115, 2012
21）Haji Y, Mizuma M, Hayashi H, et al：A case of distal cholangiocarcinoma with high sensitivity to neoadjuvant chemoradiation therapy. Gan To Kagaku Ryoho 38：2426-2428, 2011
22）Kamo N, Mori A, Nitta T, et al：Two cases of curatively resected intrahepatic cholangiocellular carcinomas through effective response to neoadjuvant chemotherapy. Gan To Kagaku Ryoho 38：305-308, 2011
23）Kato H, Tabata M, Kobayashi M, et al：Aggressive surgical resection after neoadjuvant chemoradiation therapy for locally advanced intrahepatic cholangiocarcinoma. Clin J Gastroenterol 2：351-354, 2009
24）Kawabata Y, Yano S, Ohishi T, et al：A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy. Gan To Kagaku Ryoho 26：365-368, 1999
25）Kobayashi S, Gotoh K, Takahashi H, et al：Clinicopathological features of surgically-resected biliary tract cancer following chemo-radiation therapy. Anticancer Res 36：335-342, 2016
26）Kato A, Shimizu H, Ohtsuka M, et al：Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery. Ann Surg Oncol 22（Suppl 3）：S1093-1099, 2015
27）Kobayashi S, Tomokuni A, Gotoh K, et al：Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer. Cancer Chemother Pharmacol 76：1191-1198, 2015
28）Kato A, Shimizu H, Ohtsuka M, et al：Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer：a retrospective single-center study. Ann Surg Oncol 20：318-324, 2013
29）Katayose Y, Rikiyama T, Motoi F, et al：Phase Ⅰ trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients（NACRAC study）. Hepatogastroenterology 58：1866-1872, 2011
30）Czito BG, Hong TJ, Cohen DP, et al：A phase Ⅰ study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract. Cancer Invest 24：9-17, 2006
31）de Aretxabala X, Losada H, Mora J, et al：Neoadjuvant chemoradiotherapy in gallbladder cancer. Rev Med Chil 132：51-57, 2004
32）McMasters KM, Tuttle TM, Leach SD, et al：Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174：605-608, 1997
33）De Vreede I, Steers JL, Burch PA, et al：Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6：309-316, 2000
34）Rea DJ, Heimbach JK, Rosen CB, et al：Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242：451-458, 2005
35）Sudan D, DeRoover A, Chinnakotla S, et al：Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2：774-779, 2002
36）Darwish Murad S, Kim WR, et al：Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 143：88-98, 2012
37）Kobayashi S, Werneburg NW, Bronk SF, et al：Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Gastroenterology 128：2054-2065, 2005
38）Isomoto H, Kobayashi S, Werneburg NW, et al：Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Hepatology 42：1329-1338, 2005
39）Yamada D, Kobayashi S, Wada H, et al：Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer. Eur J Cancer 49：1725-1740, 2013
40）Nakashima S, Kobayashi S, Nagano H, et al：BRCA/Fanconi anemia pathway implicates chemo-resistance to gemcitabine in biliary tract cancer. Cancer Sci 106：584-591, 2015
41）Nakashima S, Kobayashi S, Sakai D, et al：Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer. J Surg Oncol 110：1016-1022, 2014
42）Sakamoto T, Kobayashi S, Yamada D, et al：A histone deacetylase inhibitor suppresses epithelial-mesenchymal transition and attenuates chemoresistance in biliary tract cancer. PLoS One 11：e0145985, 2016
ログイン
ランキング
お知らせ
ログイン
